The UroOnc Minute: Neoadjuvant Therapy Before Radical Prostatectomy, With Isaac Y. Kim, MD, PhD, MBA
Isaac Y. Kim, MD, PhD, MBA, joins to discuss the evolving data surrounding neoadjuvant therapy before radical prostatectomy in prostate cancer.
|Podcasts|September 9, 2021
Dr. Krambeck investigates efficacy of Trilogy and ShockPulse-SE lithotripters
Author(s)Urology Times staff
“You have tradeoffs with every device that you use,” says Amy E. Krambeck, MD.
Advertisement
In this episode, Urology Times® Managing Editor Ben Saylor spoke with Amy E. Krambeck, MD. She discusses the recent Journal of Endourology study, "Multi-institutional prospective randomized control trial of novel intracorporeal lithotripters: ShockPulse-SE vs Trilogy trial," for which she served as senior author. Krambeck is a professor of urology at Northwestern University Feinberg School of Medicine in Chicago, Illinois.
Advertisement
Related to this article
Marian Cuello joins to discuss sexual wellness and the importance of normalizing conversations about sexual health for all individuals.
These FAQs outline key recommendations and practical takeaways from the 2026 AUA Medical Management of Kidney Stones guideline amendment.
Jonathan Harper, MD, discusses findings from the PUSH trial may inform counseling on hydration and stone recurrence.
In this episode, Karen Bigman, MBA, joins to discuss sexual health, intimacy, and relationship challenges facing adults as they navigate midlife and beyond.
In this episode, Surena F. Matin, MD, FACS, discusses the evidence and practical considerations surrounding perioperative intravesical chemotherapy to reduce bladder recurrence after nephroureterectomy.
Advertisement
Advertisement
Trending on Urology Times
1
Evidence for Combining Prostatic Urethral Lift With Radiotherapy
2
After curative-intent treatment, prostate cancer recurrence is still an unmet need
3
Rezūm outperforms combination pharmacotherapy for BPH symptoms at 1 year
4
AACU, WOCN Society urge safeguards in Medicare catheter bidding
5